1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
(
- Contribution to journal › Article
-
Mark
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
(
- Contribution to journal › Article
-
Mark
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
(
- Contribution to journal › Article
- 2003
-
Mark
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
(
- Contribution to journal › Article
- 2000
-
Mark
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
(
- Contribution to journal › Article
- 1998
-
Mark
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./Ml. Prostate specific antigen
(
- Contribution to journal › Article